Mildly raised tricuspid regurgitant velocity 2.5-3.0 m/s in pregnant women with sickle cell disease is not associated with poor obstetric outcome - An observational cross-sectional study

Pulmonary hypertension is associated with 36% mortality in pregnancy, and 6-10% of patients with sickle cell disease have pulmonary hypertension. Tricuspid regurgitant velocity ≥2.5 m/s on echocardiography is a well validated means of screening for pulmonary hypertension in the non-pregnant population. This is a pilot study to determine if this is a useful non-invasive screening test for pulmonary hypertension in pregnancy, and whether raised tricuspid regurgitant velocity ≥2.5 m/s was associated with poor outcomes. This is a cross-sectional study over a five-year period in a tertiary referral centre with a specialised multidisciplinary clinic for pregnant women with sickle cell disease. Women with sickle cell disease, no prior pulmonary hypertension and singleton pregnancies who had echocardiography with a measurable tricuspid regurgitant velocity in pregnancy were included. There were 34 pregnancies, of which eight had tricuspid regurgitant velocity ≥2.5 m/s. There were no significant differences in their characteristics, sickle cell-related complications or medical co-morbidities. The women with tricuspid regurgitant velocity ≥2.5 m/s had similar obstetric and perinatal outcomes as those with a tricuspid regurgitant velocity <2.5 m/s.

Medienart:

Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Obstetric medicine - 9(2016), 4 vom: 02. Dez., Seite 160-163

Sprache:

Englisch

Beteiligte Personen:

Soh, May C [VerfasserIn]
Sankaran, Srividhya [VerfasserIn]
Chung, Natali Ya [VerfasserIn]
Nelson-Piercy, Catherine [VerfasserIn]
Howard, Jo [VerfasserIn]
Robinson, Sue E [VerfasserIn]
Oteng-Ntim, Eugene [VerfasserIn]

Themen:

Journal Article
Obstetric outcomes
Pregnancy
Pulmonary hypertension
Sickle cell disease
Tricuspid regurgitant velocity

Anmerkungen:

Date Revised 30.09.2020

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM26606910X